Very low activated factor VII and reduced factor VII antigen in familial abetalipoproteinaemia

Thrombosis and Haemostasis

Volumn 80, Issue 2, 1998, Pages 233-238

  Miller, G J ^a,d   Mitropoulos, K A ^a   Nanjee, M N ^b   Howarth, D J ^a   Martin, J C ^a   Esnouf, M P ^c   Reeves, B E A ^a   Miller, N E ^b   Cooper, J A ^a  

^a Med Res Cncl Epidemiol Med C   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c RADCLIFFE INFIRMARY   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 9; FATTY ACID; PROTEIN C; PROTHROMBIN; TISSUE FACTOR PATHWAY INHIBITOR; TRIACYLGLYCEROL;

ABETALIPOPROTEINEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; HEMOPHILIA B; HUMAN; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031825901     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615179     Document Type: Article

References (71)

1. Miller GJ, Stirling Y, Esnouf M P, Heinrich J, van de Loo J, Kienast J, Wu KK, Morrissey JH, Meade TW, Martin JC, Imeson JD, Cooper JA, Finch A. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71: 38-48.
2. Ruddock V, Meade TW. Factor VII activity and ischaemic heart disease: fatal and non-fatal events. Q J Med 1994; 87:403-6.
3. Junker R, Heinrich J, Schulte H, van de Loo J, Assmann G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vase Biol 1997; 17: 1539-44.
4. Constantino M, Merskey C, Kudzma DJ, Zucher MB. Increased activity of vitamin-K dependent clotting factors in human hyperlipoproteinaemia-association with cholesterol and triglyceride levels. Thromb Haemost 1977; 38:465-74.
5. Fuller JH, Keen H, Jarrett RJ, Omer T, Meade TW, Chakrabarti R, North WRS, Stirling Y. Haemostatic variables associated with diabetes and its complications. Br Med J 1979; 2: 964-6.
6. Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Wu KK for the ARIC Study Investigators. Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Haemost 1993; 70: 762-7.
7. ECAT Angina Pectoris Study Group. ECAT angina pectoris study: baseline associations of haemostatic risk factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 1993; 14: 8-17.
8. Bruckert E, Ankri A, Jury M, Turpin G, De Gennes JL. Mild liver abnormalities with elevated plasma factor VII and protein C in hypertriglyceridaemic patients. Eur J Med 1993; 2; 461-5.
9. Meade TW, North WRS, Chakrabarti R, Stirling Y, Haines AP, Thompson SG. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; 1: 1050-4.
10. Miller GJ, Walter SJ, Stirling Y, Thompson SG, Esnouf MP. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249-58.
11. Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis 1991;91: 191-205.
12. Elwood PC, Beswick AD, O'Brien JR, Yarnell JWG, Layzell JC, Limb ES. Inter-relationships between haemostatic tests and the effects of some dietary determinants in the Caerphiily cohort of older men. Blood Coag Fibrinol 1993;4: 529-36.
13. Negri M, Arigliano PL, Talamini G, Carlini S, Manzato F, Bonadonna G. Levels of plasma factor VII and factor VII activated forms as a function of plasma triglyceride levels. Atherosclerosis 1993; 99: 55-61.
14. Green D, Chamberlain M A, Ruth K J, Folsom A R, Liu K. Factor VII, cholesterol, and triglycerides. The CARDIA study. Arterioscler Thromb Vasc Biol 1997; 17:51-5.
15. Wright D, Poller L, Thomson JM, Gowland E, Burrows GE. The interrelationship of factor VII and its activity state with plasma lipids in healthy adult males. Br J Haematol 1993; 85: 348-51.
16. Huffman CJ, Miller RH, Hultin MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides, in healthy young adults. Arterioscler Thromb 1992; 12: 267-70.
17. Howard PR, Bovill EG, Pike J, Church WR, Traey RP. Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 1994; 72: 21-7.
18. Miller GJ. Risk of thrombosis and the prethrombotic state. In: Atherosclerosis X. Woodford FP, Davignon J, Sniderman A (eds). Amsterdam: Elsevier 1995; pp 801-4.
19. Miller GJ, Martin JC, Webster J, Wilkes H, Miller NE, Wilkinson WH, Meade TW. Association between dietary fat intake and plasma factor VII coagulant activity - a predictor of cardiovascular mortality. Atherosclerosis 1986; 60: 269-77.
20. Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, Ehnholm C. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis 1993; 103: 1-11.
21. Silveira A, Karpe F, Blomback M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb 1994; 14: 60-9.
22. Miller GJ, Martin JC, Mitropoulos KA, Esnouf MP, Cooper JA, Morrissey JH, Howarth DJ, Tuddenham EGD. Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency. Blood 1996; 87: 4187-96.
23. Baron JA, Mann J, Stukel T. Effect of weight loss on coagulation factors VII and X. Am J Cardiol 1989; 64: 519-22.
24. Slabber M, Barnard HC, Kuyl JM, Badenhorst CJ. Effect of a short-term very low calorie diet on plasma lipids, fibrinogen, and factor VII in obese subjects. Clin Biochem 1992; 25: 334-5.
25. Palareti G, Legnani C, Poggi M, Parenti M, Babini AC, Biagi R, Baraldi L, Luchi A, Capelli M. Coccheri S. Prolonged very low calorie diet in obese subjects reduces factor VII and PAI but not fibrinogen levels. Fibrinolysis 1994; 8: 16-21.
26. Elkeles RS, Chakrabarti R, Vickers M, Stirling Y, Meade TW. Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J 1980; 2: 973-4.
27. Simpson HCR, Mann JI, Meade TW, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; 1: 786-90.
28. Bruckert E, Carvalho de Sousa J, Giral P, Soria C, Chapman M J, Caen J, de Gennes J-L. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia. Atherosclerosis 1989; 75: 129-34.
29. Mitropoulos KA, Armitage JM, Collins R, Meade TW, Reeves BEA, Wallendszus KR, Wilson SS, Lawson A, Peto R for the Oxford Cholesterol Study Group. Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. Eur Heart J 1997; 18: 235-41.
30. Avellone G, di Garbo V, Cordova R, Ranelli G, de Simone R, Bompiani G. Effect of gemfibrozil treatment on fibrinolysis system in patients with hypertriglyceridemia. Curr Therap Res 1992; 52: 338-48.
31. Avellone G, de Garbo V, Cordova R, Ranelli G, de Simone R, Bompiani G. Changes induced by pravastatin treatment on hemostatic and fibrinolytic patterns in patients with type IIβ hyperlipoproteinemia. Curr Therap Res 1994; 55: 1335-44.
32. Marckmann P, Sandstrom B, Jespersen J. Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis 1990; 80: 227-33.
33. Miller GJ, Stirling Y, Howarth DJ, Cooper JA, Green FR, Lane A, Humphries SE. Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 1995; 73: 893.
34. Broijersen A, Hamsten A, Silveira A, Fatah K, Goodall AH, Eriksson M, Angelin B, Hjemdahl P. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII. Thromb Haemost 1996; 76: 171-6.
35. Mitropoulos KA, Miller GJ, Watts GF, Durrington PN. Lipolysis of triglyceride-rien lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency. Atherosclerosis 1992; 95: 119-25.
36. Marckmann P, Sandstrom B, Jespersen J. Low fat, high-fiber diet favorably affects several independent risk markers of ischaemic heart disease: observalions on blood lipids, coagulation, and fibrinolysis from a trial of middleaged Danes. Am J Clim Nutr 1994; 59: 935-9.
37. Brace LD, Gittler-Buffa C, Miller GJ, Cole TG, Schmeisser D, Prewitt TE, Bowen PE. Factor VII coagulant activity and cholesterol changes in premenopausal women consuming a long-term cholesterol-lowering diet. Arterioscler Thromb 1994; 14: 1284-9.
38. Kasim SE, Martino S, Kim PN, Khilnani S. Boomer A, Depper J, Reading BA, Heilbrun LK. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. Am J Clin Nutr 1993; 57: 146-53.
39. Campos H, Dreon DM, Krauss RM. Association of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 1995; 36: 462-72.
40. Sharp D, Blinderman L, Combs KA, Kienzle B, Ricci B, Wager-Smith K, Gil CM, Turck CW, Bouma M-E, Rader DJ, Aggerbeck LP, Gregg RE, Gordon DA, Wetteran JR. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 1993: 365: 65-9.
41. Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the β apolipoproteins. In: The Metabolic Basis of Inherited Diseases. Scriver CR, Beaudet AL, Sly WS (eds), 6th ed. New York: McGraw-Hill 1989; pp 1139-64.
42. Slack J, Nair S, Traisman H, Becker G, Mahler S, Yi-Yung Hsia D. Lipoprotein lipase in cystic fibrosis of the pancreas. J Lab Clin Med 1962; 59: 302-8.
43. Kuo PT, Bassett DR, di George AM, Carpenter GG. Lipolytic activity of post-heparin plasma in hyperlipemia and hypolipemia. Circ Res 1965; 16: 221-9.
44. Illingworth DR, Alam SS, Alam NA. Lipoprotein lipase and hepatic lipase activity after heparin administration in abetalipoproteinemia and hypobetalipoproteinemia. Metabolism 1983; 32: 869-73.
45. Barnard G, Fosbrooke AS, Lloyd JK. Neutral lipids of plasma and adipose tissue in a-betalipoproteinaemia. Clin Chim Acta 1970; 28: 417-22.
46. Novotny WF, Girard TJ, Miletich JP, Broze GJ. Purification and characterization of the lipoprotein associated coagulation inhibitor from human plasma. J Biol Chem 1989; 264: 18832-7.
47. Mitropoulos KA, Reeves BEA, Miller GJ. The activation of factor VII in citrated plasma by charged long-chain saturated fatty acids at the interface of triglyceride-rich lipoproteins. Blood Coag Fibrinol 1993; 4: 943-51.
48. Narcisi TME, Shoulders CC, Chester SA, Read J, Brett DJ, Harrison GB, Grantham TT, Fox MF, Povey S, de Bruin TW A, Erkelens DW, Muller DPR, Lloyd JK, Scott J. Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am J Hum Genet 1995; 57: 1298-310.
49. Nanjee MN, Miller NE. Sequential microenzymatic assay of cholesterol, triglycerides and phospholipids in a single aliquot. Clin Chem 1996; 42: 915-26.
50. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345-53.
51. Dole VP, Meinertz H. Microdetermination of long chain fatty acids in plasma and tissues. J Biol Chem 1960; 235: 2595-9.
52. Mitropoulos KA, Miller GJ, Martin JC, Reeves BEA, Cooper J. Dietary fat induces changes in factor VII coagulant activity through effects on plasma free stearic acid concentration. Arterioscler Thromb 1994; 14: 214-22.
53. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44.
54. Mitropoulos KA, Reeves BEA. O'Brien DP, Cooper JA, Martin JC. The relationship between factor VII coagulant activity and factor XII activation induced in plasma by endogenous or exogenously added contact surface. Blood Coagul Fibrinol 1993: 4: 223-33.
55. Denson KWE. The specific assay of Prower-Stuart factor and factor VII. Acta Haematol 1961: 25: 105-20.
56. Denson KWE, Borrett R, Biggs R. The specific assay of prothrombin using the Taipan snake venom. Br J Haematol 1971: 21: 219.
57. von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fihrinogens. Acta Haemaiol 1957; 17: 237-46.
58. Ford RP, Esnouf MP, Burgess AI, Sarphie AF. An enzyme linked immunosorbent assay (ELISA) for the measurement of activated factor XII (Hageman Factor) in human plasma. J lmmunoassay 1996; 17: 119-31.
59. Sandset PM, Larzen ML, Abildgaard U, Lindahl AK, Odegaard OR. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Blood Coagul Fibrinol 1991; 2: 425-33.
60. Scanu AM, Aggerbeck. LP, Kruski AW, Lim CT, Kayden HJ. A study of the abnormal lipoproteins in abetalipoproteinemia. J Clin Invest 1974; 53: 440-53.
61. Aguie GA, Rader DJ, Clavey V, Traber MG, Torpier G, Kayden HJ, Fruchart JC, Brewer HB, Castro G. Lipoproteins containing apolipoprotein β isolated from patients with abetalipoproteinemia and homozygous hypobetalipoproteinemia: identification and characterization. Atherosclerosis 1995; 188: 183-91.
62. Lim CT, Chung J, Kayden HJ, Scanu AM. Apoproteins of human serum high density lipoproteins. Isolation and characterization of the peptides of Sephadex fraction V from normal subjects and patients with abeta-lipoproteinemia. Biochem & Biophys Acta 1976; 420: 332-41.
63. Illingworth DR, Connor WE, Miller RG. Abetalipoproteinemia: report of two cases and review of therapy. Arch Neurol 1980; 37: 659-62.
64. Caballero FM, Buchanan GR. Abetalipoproteinemia presenting as severe vitamin K deficiency. Pediatrics 1980; 65: 161-3.
65. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and hemophilia B patients. Blood 1992; 80: 25-8.
66. Mitropoulos KA, Esnouf MP. The prothrombin activation peptide regulates synthesis of the vitamin K-dependent proteins in the rabbit. Thromb Res 1990; 57: 541-9.
67. Mitropoulos KA, Miller GJ, Howarth DJ, Reeves BE, Cooper JA. The effects of intravenous Triton WR-1339 on factor VII coagulant activity and plasma lipoproteins in normocholesterolaemic and hypercholesterolaemic rabbits. Blood Coagul Fibrinol 1994; 5: 583-91.
68. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze GJ. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood 1991; 78: 387-93.
69. Hallberg D. Studies on the elimination of exogenous lipids from the blood stream. Acta Physiol Scand 1964; 62: 407-10.
70. Boberg J, Carlson LA. Determination of heparin-induced lipoprotein lipase activity in human plasma. Clin Clin Acta 1964; 10: 420-7.
71. Miller GJ, Esnouf MP, Burgess AI, Cooper JA, Mitchell JP. Risk of coronary heart disease and activation of factor XII in middle-aged men. Arterioscler Thromb Vase Biol 1997; 17: 2103-6.